New Paradigms for CKD Management in Patients With T2D.

IF 1.3 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Journal of Family Practice Pub Date : 2023-07-01 DOI:10.12788/jfp.0621

Joshua J Neumiller, Stephen A Brunton

引用次数: 0

Abstract

Learning objectives: At the end of the activity, participants will be able to: Identify the risks of kidney disease and their consequences in patients with type 2 diabetes (T2D). Appropriately screen for the presence of chronic kidney disease (CKD) in patients with T2D. Initiate evidence-based therapy to slow the progression of kidney disease in patients with T2D and CKD. Become familiar with the novel nonsteroidal mineralocorticoid receptor antagonist finerenone and its role in the treatment of patients with T2D and CKD.

查看原文本刊更多论文

T2D患者CKD管理的新范式。

学习目标:活动结束时，参与者将能够:识别2型糖尿病(T2D)患者肾脏疾病的风险及其后果。适当筛查T2D患者是否存在慢性肾病(CKD)。启动循证治疗以减缓T2D和CKD患者肾脏疾病的进展。熟悉新型非甾体类矿物皮质激素受体拮抗剂芬烯酮及其在治疗T2D和CKD患者中的作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Family Practice PRIMARY HEALTH CARE-MEDICINE, GENERAL & INTERNAL

CiteScore

0.50

自引率

0.00%

发文量

130

审稿时长

6-12 weeks

期刊介绍： JFP is a peer-reviewed medical journal specifically intended to meet the needs of the specialty of family medicine. JFP is delivered to more than 95,000 family physicians as well as general practitioners and osteopaths in primary care.